Neurocrine Current ratio
3.2
Last period Current ratio
-31%
Current ratio has decreased in 5 years
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Neurocrine
Company Analysis
NBIX valuation, rating, competitors, insights and company profile
Eyestock Rating
NBIX financial analysis by Eyestock methodology
Valuation
NBIX valuation using historical relative method
Financials
NBIX revenue, earnings, ROE, ROIC and other financials
Statements
NBIX Income Statements, Balance Sheet and Cash Flow Statements
Dividends
NBIX dividend yield and annual dividend
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
What is Current ratio of Neurocrine ?
Neurocrine`s Current ratio for the last twelve months ended 2024-09-30 is 3.2